Cargando…

Neoadjuvant Lorlatinib Induces Pathological Complete Response in Advanced ALK-Positive Lung Cancer: A Case Report

Patient: Male, 54-year-old Final Diagnosis: Lung adenocarcinoma Symptoms: Cough Clinical Procedure: — Specialty: Oncology • Pulmonology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Chemotherapy has been the conventional treatment method for advanced non-small-cell lung cancer (NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Liu, Junwei, Zhang, Guqin, Hu, Weidong, Wang, Xianguo, Liu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642716/
https://www.ncbi.nlm.nih.gov/pubmed/37934724
http://dx.doi.org/10.12659/AJCR.942150